Kathleen M. Whalen, SVP & Chief Ethics Officer at HCA Healthcare, Inc. (HCA), sold 14,995 shares at $359.92 ($5.4M) on 2024-07-29, disclosed to the SEC on 2024-07-31.
Open-market sale of $5.4M HCA by SVP & Chief Ethics Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $358.73 | 5,293 | $1.9M | 35.1% |
| 2 | $359.92 | 1,864 | $671K | 12.4% |
| 3 | $359.92 | 1,864 | $671K | 12.4% |
| 4 | $363.51 | 2,987 | $1.1M | 20.1% |
| 5 | $363.51 | 2,987 | $1.1M | 20.1% |
| Total | $360.93 avg | 14,995 |
| $5.4M |
| 100% |
| Filing → |
| HCA | SELL | 2024-02-13 | $2.6M | — | Filing → |
| HCA | SELL | 2023-08-07 | $787K | — | Filing → |
| HCA | SELL | 2023-02-22 | $914K | — | Filing → |